231 related articles for article (PubMed ID: 29632073)
1. Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.
Mondragón-Rodríguez S; Salas-Gallardo A; González-Pereyra P; Macías M; Ordaz B; Peña-Ortega F; Aguilar-Vázquez A; Orta-Salazar E; Díaz-Cintra S; Perry G; Williams S
J Biol Chem; 2018 Jun; 293(22):8462-8472. PubMed ID: 29632073
[TBL] [Abstract][Full Text] [Related]
2. Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis.
Hollnagel JO; Elzoheiry S; Gorgas K; Kins S; Beretta CA; Kirsch J; Kuhse J; Kann O; Kiss E
PLoS One; 2019; 14(1):e0209228. PubMed ID: 30645585
[TBL] [Abstract][Full Text] [Related]
3. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
4. Differential accumulation of Tau phosphorylated at residues Thr231, Ser262 and Thr205 in hippocampal interneurons and its modulation by Tau mutations (VLW) and amyloid-β peptide.
Dávila-Bouziguet E; Targa-Fabra G; Ávila J; Soriano E; Pascual M
Neurobiol Dis; 2019 May; 125():232-244. PubMed ID: 30553886
[TBL] [Abstract][Full Text] [Related]
5. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
Rodriguez GA; Barrett GM; Duff KE; Hussaini SA
PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
Ruan Z; Pathak D; Venkatesan Kalavai S; Yoshii-Kitahara A; Muraoka S; Bhatt N; Takamatsu-Yukawa K; Hu J; Wang Y; Hersh S; Ericsson M; Gorantla S; Gendelman HE; Kayed R; Ikezu S; Luebke JI; Ikezu T
Brain; 2021 Feb; 144(1):288-309. PubMed ID: 33246331
[TBL] [Abstract][Full Text] [Related]
7. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment.
Hatch RJ; Wei Y; Xia D; Götz J
Acta Neuropathol; 2017 May; 133(5):717-730. PubMed ID: 28091722
[TBL] [Abstract][Full Text] [Related]
8. Consequences of hyperphosphorylated tau on the morphology and excitability of hippocampal neurons in aged tau transgenic mice.
Müller-Thomsen L; Borgmann D; Morcinek K; Schröder S; Dengler B; Moser N; Neumaier F; Schneider T; Schröder H; Huggenberger S
Neurobiol Aging; 2020 Sep; 93():109-123. PubMed ID: 32278495
[TBL] [Abstract][Full Text] [Related]
9. Excitatory Inputs Determine Phase-Locking Strength and Spike-Timing of CA1 Stratum Oriens/Alveus Parvalbumin and Somatostatin Interneurons during Intrinsically Generated Hippocampal Theta Rhythm.
Huh CY; Amilhon B; Ferguson KA; Manseau F; Torres-Platas SG; Peach JP; Scodras S; Mechawar N; Skinner FK; Williams S
J Neurosci; 2016 Jun; 36(25):6605-22. PubMed ID: 27335395
[TBL] [Abstract][Full Text] [Related]
10. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
[TBL] [Abstract][Full Text] [Related]
11. Tau binding protein CAPON induces tau aggregation and neurodegeneration.
Hashimoto S; Matsuba Y; Kamano N; Mihira N; Sahara N; Takano J; Muramatsu SI; Saido TC; Saito T
Nat Commun; 2019 Jun; 10(1):2394. PubMed ID: 31160584
[TBL] [Abstract][Full Text] [Related]
12. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
[TBL] [Abstract][Full Text] [Related]
13. Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau.
Dickstein DL; Brautigam H; Stockton SD; Schmeidler J; Hof PR
Brain Struct Funct; 2010 Mar; 214(2-3):161-79. PubMed ID: 20213269
[TBL] [Abstract][Full Text] [Related]
14. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
15. Neuronal network activity in the hippocampus of tau transgenic (Tg4510) mice.
Scott L; Kiss T; Kawabe TT; Hajós M
Neurobiol Aging; 2016 Jan; 37():66-73. PubMed ID: 26610388
[TBL] [Abstract][Full Text] [Related]
16. Hyperphosphorylated Tau Relates to Improved Cognitive Performance and Reduced Hippocampal Excitability in the Young rTg4510 Mouse Model of Tauopathy.
Xolalpa-Cueva L; García-Carlos CA; Villaseñor-Zepeda R; Orta-Salazar E; Díaz-Cintra S; Peña-Ortega F; Perry G; Mondragón-Rodríguez S
J Alzheimers Dis; 2022; 87(2):529-543. PubMed ID: 35342085
[TBL] [Abstract][Full Text] [Related]
17. Functional Connectivity between Hippocampus and Lateral Septum is Affected in Very Young Alzheimer's Transgenic Mouse Model.
Mondragón-Rodríguez S; Gu N; Fasano C; Peña-Ortega F; Williams S
Neuroscience; 2019 Mar; 401():96-105. PubMed ID: 30599271
[TBL] [Abstract][Full Text] [Related]
18. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
[TBL] [Abstract][Full Text] [Related]
19. Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer's disease pathology.
Ahnaou A; Moechars D; Raeymaekers L; Biermans R; Manyakov NV; Bottelbergs A; Wintmolders C; Van Kolen K; Van De Casteele T; Kemp JA; Drinkenburg WH
Sci Rep; 2017 Oct; 7(1):14189. PubMed ID: 29079799
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
